26 related articles for article (PubMed ID: 38554333)
1. Evaluation of differences in expression pattern of three isoforms of the transforming growth factor beta in patients with lumbosacral stenosis.
Sobański D; Bogdał P; Staszkiewicz R; Sobańska M; Filipowicz M; Czepko RA; Strojny D; Grabarek BO
Cell Cycle; 2024 Mar; 23(5):555-572. PubMed ID: 38695374
[TBL] [Abstract][Full Text] [Related]
2. Correlation between Vascularity and Advancing Histological Grades of Oral Submucous Fibrosis with a Plausible Role in Malignisation: Systematic review of a persisting matter of conflict.
Pandiar D; Nair SK; Bologna-Molina R; Krishnan RP; Sivakumar N; Anand R; Chaudhari S; Sharma P
Sultan Qaboos Univ Med J; 2024 May; 24(2):152-160. PubMed ID: 38828241
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta in oral submucous fibrosis.
Rai A; Ahmad T; Parveen S; Parveen S; Faizan MI; Ali S
J Oral Biol Craniofac Res; 2020; 10(2):166-170. PubMed ID: 32489816
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of alpha smooth muscle actin correlates with serum transforming growth factor-β1 levels in oral submucous fibrosis.
Singh I; Juneja S; Tandon A; Jain A; Shetty DC; Sethi A
J Investig Clin Dent; 2019 Nov; 10(4):e12473. PubMed ID: 31631564
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts.
Maria S; Kamath VV; Satelur K; Rajkumar K
J Cancer Res Ther; 2016; 12(1):379-85. PubMed ID: 27072267
[TBL] [Abstract][Full Text] [Related]
6. In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.
Kinnman N; Andersson U; Hultcrantz R
Scand J Gastroenterol; 2000 Dec; 35(12):1294-300. PubMed ID: 11199370
[TBL] [Abstract][Full Text] [Related]
7. Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors.
Thangjam GS; Agarwal P; Balapure AK; Rao SG; Kondaiah P
J Periodontal Res; 2009 Dec; 44(6):736-43. PubMed ID: 19438976
[TBL] [Abstract][Full Text] [Related]
8. Salivary transforming growth factor beta in oral submucous fibrosis: A diagnostic and predictive marker.
Rai A; Parveen S; Shree P; Ahmed T; Ali S; Kaur M; Sircar K; Sybil D; Chandra A
J Cancer Res Ther; 2024 Jan; 20(1):275-280. PubMed ID: 38554333
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches.
Esmaeilzadeh A; Mohammadi V; Elahi R
Mol Biol Rep; 2023 Jul; 50(7):6121-6131. PubMed ID: 37204543
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor-β in oral submucous fibrosis: A systematic review.
Bansal SP; Pereira T; Desai RS; Jena A; Mehta V
J Oral Maxillofac Pathol; 2023; 27(2):348-358. PubMed ID: 37854915
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications.
Poniatowski ŁA; Wojdasiewicz P; Gasik R; Szukiewicz D
Mediators Inflamm; 2015; 2015():137823. PubMed ID: 25709154
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis.
Lichtman MK; Otero-Vinas M; Falanga V
Wound Repair Regen; 2016 Mar; 24(2):215-22. PubMed ID: 26704519
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
